Research output per year
Research output per year
Search results
-
2019
Long-term natalizumab treatment is associated with a reduction in lesional white matter levels of myo-inostiol, a biomarker of gliotic activity
Schoonheim, M., Jonkman, L., Eijlers, A., Meijer, K., Killestein, J. & Geurts, J., 1 Jul 2019.Research output: Contribution to conference › Poster › Academic
-
2018
Predicting conversion to secondary progressive MS: the role of MRI measures
Meijer, K., Eijlers, A., Steenwijk, M., Dekker, I., Uitdehaag, B., Barkhof, F., Geurts, J. & Schoonheim, M., 23 May 2018.Research output: Contribution to conference › Poster › Academic
-
2017
Functional brain network stability in natalizumab treated multiple sclerosis patients: a one year follow-up study
Meijer, K. A., Wiebenga, O., Eijlers, A. J., Steenwijk, M. D., Geurts, J. J. & Schoonheim, M. M., Oct 2017, p. 808-809.Research output: Contribution to conference › Poster › Academic